combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline Can dipeptidyl peptidase‑4 (DPP‑4) inhibitors be combined semaglutide ( GLP‑1 agonist)? SGLT-2 inhibitors, GLP-1 receptor agonists,

Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials

Several types of GLP-1 agonists are available

Given the natural fluctuations in hormone levels and the intricate rhythms of human physiology throughout the day and over a persons lifetime, there is concern about the uncertain health ramifications of sustained elevation of incretin activity over decades of treatment

GIP receptor agonists are thought to have limited potential as sole therapy for DMT2, although further investigation is ongoing

Curr Med Res Opin 2008;24:275286

Modulation of postprandial GLP-1 secretion and glycemic responses by a food-grade GLP-1 formula in human subjects